Genetic modification of the relationship between phosphorylated tau and neurodegeneration

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Alzheimer's & Dementia

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2013.12.022PMID 24656848PMCID PMC4169762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene-based GWAS and biological pathway analysis of the resilience of executive functioning

  2013cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  2013cited by this paper
• APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

  2013cited by this paper
• GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

  2013cited by this paper
• Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives

  2013cited by this paper
• Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

  2013cited by this paper
• Genetic Interactions within Inositol-Related Pathways are Associated with Longitudinal Changes in Ventricle Size

  2013cited by this paper
• Longitudinal brain activity changes in asymptomatic Alzheimer disease

  2012cited by this paper
• A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment

  2012cited by this paper
• Within-subject template estimation for unbiased longitudinal image analysis

  2012cited by this paper
• Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

  2012cited by this paper
• CSF tau markers are correlated with hippocampal volume in Alzheimer's disease.

  2012cited by this paper
• Asymptomatic Alzheimer's disease: a prodrome or a state of resilience?

  2011cited by this paper
• The pathological process underlying Alzheimer’s disease in individuals under thirty

  2011cited by this paper
• Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease

  2011cited by this paper
• Leukocyte Telomere Length Is Associated With High-Risk Plaques on Virtual Histology Intravascular Ultrasound and Increased Proinflammatory Activity

  2011cited by this paper
• Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort

  2011cited by this paper
• HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants

  2011cited by this paper
• Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

  2011cited by this paper
• Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease

  2011cited by this paper
• POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells

  2010cited by this paper
• Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort

  2010cited by this paper
• SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease

  2010cited by this paper
• Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Relationships between biomarkers in aging and dementia

  2009cited by this paper
• Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly

  2009cited by this paper
• Faculty Opinions recommendation of Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.

  2009cited by this paper
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease

  2009cited by this paper
• Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta

  2009cited by this paper
• Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

  2008cited by this paper
• The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods

  2008cited by this paper
• Neuronal Hypertrophy in Asymptomatic Alzheimer Disease

  2008cited by this paper
• PET imaging of amyloid deposition in patients with mild cognitive impairment.

  2008cited by this paper
• MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers

  2008cited by this paper
• PLINK: a tool set for whole-genome association and population-based linkage analyses.

  2007cited by this paper
• Inflammatory biomarkers are associated with total brain volume

  2007cited by this paper
• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006cited by this paper
• An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

  2006cited by this paper
• Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.

  2006cited by this paper
• Faculty Opinions recommendation of Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

  2006cited by this paper
• CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

  2006cited by this paper
• Mapping hippocampal and ventricular change in Alzheimer disease

  2004cited by this paper
• Expression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma

  2004cited by this paper
• Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

  2004cited by this paper
• FAST‐TRACK: Integrating QTL mapping and genome scans towards the characterization of candidate loci under parallel selection in the lake whitefish (Coregonus clupeaformis)

  2004cited by this paper
• Telomere shortening in T cells correlates with Alzheimer's disease status.

  2003cited by this paper
• The soluble interleukin 6 receptor: mechanisms of production and implications in disease

  2001influential reference
• Inference of population structure using multilocus genotype data.

  2000cited by this paper
• Cortical surface-based analysis. I. Segmentation and surface reconstruction.

  1999cited by this paper
• Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

  1999cited by this paper
• High‐resolution intersubject averaging and a coordinate system for the cortical surface

  1999cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Alzheimer’s Dementia

  1985cited by this paper

• NetPRS: SNP Interaction Aware Network-Based Polygenic Risk Score for Alzheimer's Disease

  2024cites this paper
• Genetics of Alzheimer’s Disease in the African American Population

  2023cites this paper
• Blood DNA Methylation Patterns in Older Adults With Evolving Dementia

  2022cites this paper
• Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease

  2022cites this paper
• TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease

  2021cites this paper
• The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

  2021cites this paper
• Group penalized quantile regression

  2021cites this paper
• Developing the ATX(N) classification for use across the Alzheimer disease continuum

  2021cites this paper
• Genetic variants and functional pathways associated with resilience to Alzheimer’s disease

  2020cites this paper
• Telomere length associations with cognition depend on Alzheimer's disease biomarkers

  2019cites this paper
• Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels

  2018cites this paper
• Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

  2018cites this paper
• Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

  2017cites this paper
• State of Play in Alzheimer’s Disease Genetics

  2017cites this paper
• Genome-wide association and interaction studies of CSF T-tau/Aβ42 ratio in ADNI cohort.

  2017cites this paper
• Identifying Associations between Vascular Risk Factors and Measures of Brain Health using Multimodal Magnetic Resonance Imaging

  2016cites this paper
• Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans

  2015cites this paper
• Predicting Alzheimer’s Disease Using Combined Imaging-Whole Genome SNP Data

  2015cites this paper
• Alzheimer's disease research in the context of the national plan to address Alzheimer's disease.

  2015cites this paper
• Introducing Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, an open access journal of the Alzheimer's Association

  2015cites this paper
• Genetics and Brain Morphology

  2015cites this paper
• Genetic variation modifies risk for neurodegeneration based on biomarker status

  2014influential citation